Trial Profile
RESPONSIfVE: efficacy and therapeutic response to Procoralan® in the treatment of chronic stable angina pectoris in routine medical practice a prospective non-interventional study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Aug 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Beta-adrenergic receptor antagonists
- Indications Angina pectoris
- Focus Therapeutic Use
- Acronyms RESPONSIfVE
- Sponsors Servier
- 18 Jul 2016 Results published in the Advances in Therapy
- 30 Sep 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 19 Feb 2013 New trial record